Cite

    Mendes, M. I., Smith, D. E., Pop, A., Lennertz, P., Fernandez Ojeda, M. R., Kanhai, W. A., van Dooren, S. J., Anikster, Y., Barić, I., Boelen, C., Campistol, J., de Boer, L., Kariminejad, A., Kayserili, H., Roubertie, A., Verbruggen, K. T., Vianey‐Saban, C., Williams, M., & Salomons, G. S. (2017). clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity. Human mutation, 38(5), 524–531. http://access.bl.uk/ark:/81055/vdc_100045729063.0x000005